Skip to content
MARKETS / NYSE / IEX
NYSE · PUMPS & PUMPING EQUIPMENT · LARGE CAP

Idex Corp. IEX

18 fiscal years on record · USD · FY2025 reported · SEC filings only
5 YEARS OF DIVIDEND GROWTH
$3.5B
▲ 5.8% YoY
$483.2M
▼ 4.3% YoY
$616.8M
▲ 2.3% YoY
In brief

What this company does

The Company has three reportable segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces and distributes precision fluidics, positive displacement pumps, powder and liquid processing technologies, micro-precision components, pneumatic components and sealing products, biocompatible medical devices and implantables, air compressors and blowers, and optical components and coatings, among other precision-engineered products. The FMT segment designs, produces and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors and other fluid-handling pump modules and systems, and provides flow monitoring and other services. The FSDP segment designs, produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags and other components and systems, engineered stainless steel banding and clamping devices, and precision equipment for dispensing, metering and mixing colorants and paints. At December 31, 2025, the company had approximately 8,700 employees. The company's products and services are available worldwide, with manufacturing, sales, distribution, service and/or administrative facilities located in more than 20 countries. IDEX was incorporated in Delaware on September 24, 1987.

Written from the business description in IDEX CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 19 February 2026. Every sentence was checked against that document before publication.

Growth
USD 3.5B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 3.5 · Net income 0.5
2B2008201120142017202020232025
Compound annual growth
+2.8%
+8.0%
+5.5%
+5.7%
−6.3%
+5.0%
+5.5%
+7.8%
−6.0%
+5.3%
+5.9%
+8.4%
+5.8%
+7.3%
+8.3%
+10.9%
+14.6%
+16.2%
+4.8%
+16.5%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.0% a year over five years — but profit grew slower: net income at +5.0%, earnings per share at +5.3%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
14 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 20.2% · Net 14.0%
10%20%2008201120142017202020232025
ROE
FY2025 · ROE 12.4%
10%20%2008201120142017202020232025

Each USD of equity produced 12 cents of profit this year.

Cash & shareholders
USD 460.4M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 616.8
250.0M500.0M2008201120142017202020232025
Net buybacks $M Dividends $M
FY2025 · Dividends 212.6 · Net buybacks 247.8
200M400MDividendsNet buybacks2008201120142017202020232025

USD 212.6M in dividends and USD 247.8M in buybacks — 95% of the year's profit went back to shareholders.

Total assetsUSD 6.9B
EquityUSD 4.0B
CashUSD 580.0M
Gross debtUSD 1.8B
Net debtUSD 1.2B
Current ratio2.86×

Net debt stands at 31% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011201020092008
Revenue $B3.53.33.33.22.82.42.52.52.32.12.02.12.02.01.81.51.31.5
Operating income $B0.70.70.70.80.60.50.60.60.50.40.40.40.40.10.30.20.20.2
EBITDA $B0.80.70.80.80.70.60.70.60.60.50.50.50.50.20.40.30.2·
Income tax $B0.20.10.20.20.10.10.10.10.10.10.10.10.10.00.10.10.10.1
Net income $B0.50.50.60.60.40.40.40.40.30.30.30.30.30.00.20.20.10.1
Free cash flow $B0.60.60.60.50.50.50.50.40.40.40.30.30.40.30.20.20.20.2
EPS, diluted $6.416.647.857.715.884.945.565.294.363.533.623.453.090.452.321.901.401.53
Dividend / sh $2.842.762.562.402.162.002.001.721.481.361.281.120.890.800.680.600.480.48
Payout %4441323036403531333834312917028293431
ROE %12.413.818.120.116.815.720.021.219.718.219.318.316.82.513.411.99.411.1

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 88 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 7 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPumps & Pumping Equipment
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image